<VariationArchive VariationID="1494695" VariationName="NM_000101.4(CYBA):c.472_484del (p.Pro160fs)" VariationType="Deletion" Accession="VCV001494695" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1344837" VariationID="1494695">
      <GeneList>
        <Gene Symbol="CYBA" FullName="cytochrome b-245 alpha chain" GeneID="1535" HGNC_ID="HGNC:2577" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88643289" stop="88651053" display_start="88643289" display_stop="88651053" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88709696" stop="88717491" display_start="88709696" display_stop="88717491" Strand="-" />
          </Location>
          <OMIM>608508</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000101.4(CYBA):c.472_484del (p.Pro160fs)</Name>
      <CanonicalSPDI>NC_000016.10:88643456:CGGCCGGGGGCCGCGGC:CGGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88643457" stop="88643469" display_start="88643457" display_stop="88643469" variantLength="13" positionVCF="88643456" referenceAlleleVCF="TCGGCCGGGGGCCG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88709865" stop="88709877" display_start="88709865" display_stop="88709877" variantLength="13" positionVCF="88709864" referenceAlleleVCF="TCGGCCGGGGGCCG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>P160fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_52" sequenceAccession="LRG_52">
            <Expression>LRG_52:g.12581_12593del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.88643461_88643473del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.88643461_88643473del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.88709869_88709881del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.88709869_88709881del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007291.1" sequenceAccession="NG_007291" sequenceVersion="1" change="g.12581_12593del">
            <Expression>NG_007291.1:g.12581_12593del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000101.4" sequenceAccession="NM_000101" sequenceVersion="4" change="c.472_484del" MANESelect="true">
            <Expression>NM_000101.4:c.472_484del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000092.2" sequenceAccession="NP_000092" sequenceVersion="2" change="p.Pro160fs">
            <Expression>NP_000092.2:p.Pro160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1272232395" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000101.4(CYBA):c.472_484del (p.Pro160fs) AND Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative" Accession="RCV002015070" Version="5">
        <ClassifiedConditionList TraitSetID="578">
          <ClassifiedCondition DB="MedGen" ID="C1856255">Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000101.4(CYBA):c.472_484del (p.Pro160fs) AND not specified" Accession="RCV002307826" Version="1">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-05" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-30" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">20167518</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30716179</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34547651</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="578" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1396" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative</ElementValue>
                <XRef ID="Granulomatous+disease%2C+chronic%2C+autosomal+recessive%2C+cytochrome+b-negative/8493" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009308" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CGD DUE TO DEFICIENCY OF THE ALPHA SUBUNIT OF CYTOCHROME b</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-NEGATIVE</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYBA DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15175" />
                <XRef ID="15175" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi. CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory responses resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis). Granulomas typically involve the genitourinary system (bladder) and gastrointestinal tract (often the pylorus initially, and later the esophagus, jejunum, ileum, cecum, rectum, and perirectal area). Some males with X-linked CGD have McLeod neuroacanthocytosis syndrome as the result of a contiguous gene deletion. While CGD may present anytime from infancy to late adulthood, the vast majority of affected individuals are diagnosed before age five years. Use of antimicrobial prophylaxis and therapy has greatly improved overall survival.</Attribute>
                <XRef ID="NBK99496" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876374</ID>
                <ID Source="BookShelf">NBK99496</ID>
              </Citation>
              <XRef ID="379" DB="Orphanet" />
              <XRef ID="C1856255" DB="MedGen" />
              <XRef ID="MONDO:0009308" DB="MONDO" />
              <XRef Type="MIM" ID="233690" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5082434" SubmissionDate="2022-11-10" DateLastUpdated="2022-11-19" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="NM_000101.3:c.472_484del13|MedGen:CN169374" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002600887" DateUpdated="2022-11-19" DateCreated="2022-11-19" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">34547651</ID>
          </Citation>
          <Comment>Variant summary: CYBA c.472_484del13 (p.Pro160AlafsX27), located in the last exon (exon 6) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have not been observed or classified by our laboratory. The variant allele was found at a frequency of 1.6e-05 in 127968 control chromosomes and annotated as a low confidence truncation located in the last-filter position of the transcript. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.472_484del13 has been reported in the literature with an unclear phenotype (A22?) and a non-informative genotype (exact zygosity and genotype not specified) in two families with at-least 3 alleles in the latest update on autosomal forms of chronic granulomatous disease (example, Roos_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Chronic Granulomatous Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified this variant and several downstream truncations as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000101.3:c.472_484del13</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12274151</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4300421" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4933627|MedGen:C1856255" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002285600" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20167518</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34547651</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30716179</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro160Alafs*27) in the CYBA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 36 amino acid(s) of the CYBA protein. This variant is present in population databases (no rsID available, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with chronic granulomatous disease (PMID: 20167518, 34547651; Invitae; external communication). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1494695). This variant disrupts the C-terminus of the CYBA protein. Other variant(s) that disrupt this region (p.Lys166Argfs*17) have been observed in individuals with CYBA-related conditions (PMID: 30716179). This suggests that this may be a clinically significant region of the protein. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.88709865_88709877del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1856255" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4300421" TraitType="Disease" MappingType="XRef" MappingValue="C1856255" MappingRef="MedGen">
        <MedGen CUI="C1856255" Name="Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5082434" TraitType="Disease" MappingType="XRef" MappingValue="CN169374" MappingRef="MedGen">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

